Deals
Upsher-Smith Laboratories Inc offers to acquire Proximagen Group
Upsher-Smith Laboratories Inc has made a recommended offer for the entire issued and to be issued share capital of Proximagen Group (PRX). The offer values the entire issued ordinary share capital of PRX at approximately £223 million.
Value: $267 million
Announced: June 13 2012
| Parties involved | Legal advisers |
|---|---|
| Upsher-Smith Laboratories Inc | Skadden Arps Slate Meagher & Flom LLP |
| Proximagen Group | Pinsent Masons , Reed Smith LLP |
Powered by
